EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients

Qingyong Xu iD, Nigar A Khurram iD, Carol Bentlejewski iD, Anthony J Demetris iD, Adriana Zeevi iD

Clinical Transplantation · 2026

DOI: 10.1111/ctr.70480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2026. Verfasst von Qingyong Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transplant Pathology, Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Graft Rejection, Liver Transplantation, Isoantibodies, HLA Antigens. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antibodies to donor HLA (DSA) and non‐HLA antigens are associated with detrimental outcomes in kidney, heart, and lung transplants. Such data are scarce in liver transplants (LTx). We aim to study the roles of DSA and non‐HLA antibodies in T‐cell‐mediated rejection (TCMR) of LTx.

Methods

Allograft biopsies ( n = 103) from adult LTx recipients were studied. Biopsy‐paired serums were retrospectively tested for anti‐angiotensin II type 1 receptor (AT1R) and the Luminex panel of 60 non‐HLA Antibodies.

Results

TCMR was detected in 59 of 103 (57.3%) biopsies. Twenty‐six biopsies were categorized as moderate‐severe (MS‐TCMR), 77 as negative‐mild (NM‐TCMR). DSA was positive in 95/103 (92.2%) cases and wasn't associated with MS‐TCMR. Anti‐AT1R antibodies were elevated in serum paired with MS‐TCMR vs. NM‐TCMR (18.8[15.2–40.0] vs. 13.0[10.0–21.5] U/ml, p < 0.01). Positive anti‐AT1R antibodies were associated with a higher incidence of MS‐TCMR (HR = 12.4[1.5–101.6], p = 0.02). A panel of 18 non‐HLA Abs was significantly associated with MS‐TCMR. The number of panel‐18 non‐HLA antibodies was higher with MS‐TCMR vs. NM‐TCMR (3[2–5] vs. 1[0–1], p < 0.001). The incidence of MS‐TCMR was higher in cases with panel‐18 non‐HLA antibodies ≥3 vs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionLiver TransplantationIsoantibodiesHLA AntigensT-LymphocytesPostoperative ComplicationsHumansFemaleMaleRetrospective StudiesMiddle AgedFollow-Up StudiesPrognosisAdultReceptor, Angiotensin, Type 1Graft SurvivalRisk FactorsTissue Donors

Stichwörter der Autor:innen

DSAHLANon‐HLAantibodyliver transplantation

Substanzen

IsoantibodiesHLA AntigensReceptor, Angiotensin, Type 1

Autor:innen und Institutionen

  • Division of Transplant Pathology, Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Qingyong Xu, Nigar A Khurram, Carol Bentlejewski, Anthony J Demetris, Adriana Zeevi

Zitieren

APA

Xu, Q., Khurram, N. A., Bentlejewski, C., Demetris, A. J., & Zeevi, A. (2026). The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.70480

Vancouver

Xu Q, Khurram NA, Bentlejewski C, Demetris AJ, Zeevi A. The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients. Clinical Transplantation. 2026. doi:10.1111/ctr.70480

BibTeX
@article{Xu2026,
  author = {Xu, Qingyong and Khurram, Nigar A and Bentlejewski, Carol and Demetris, Anthony J and Zeevi, Adriana},
  title = {The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients},
  journal = {Clinical Transplantation},
  year = {2026},
  doi = {10.1111/ctr.70480}
}
Kostenlos starten →